Document ID: chunk:federal_register_of_legislation:F2023L00940:schedule:1:p4
Version: federal_register_of_legislation:F2023L00940
Segment Type: schedule
Provision Reference: sch 1 (pt 4/5)
Character Range: 31571–35934

concentration of >0.02 ppm;
(d)          carbon disulphide at an inhaled concentration of >0.3 ppm;
(e)          ethylene oxide at an inhaled concentration of >1 ppm;
(f)           methyl bromide at an inhaled concentration of >0.02 ppm;
(g)          methyl n-butyl ketone (MNBK) at an inhaled concentration of >0.6 ppm;
(h)          n-hexane at an inhaled concentration of >0.6 ppm; or
(i)            styrene at an inhaled concentration >0.2 ppm.
                               specified list of chemicals (short term exposure) means:
(a)          acrylamide monomer at an oral dose rate of >0.01 mg/kg/day;
(b)          1-bromopropane at an inhaled concentration of >1 ppm or an oral dose rate of >0.001 mg/kg/day;
(c)          carbon disulphide at an inhaled concentration of >0.3 ppm;
(d)          dimethylaminopropionitrile;
(e)          ethylene oxide at an inhaled concentration of >5 ppm;
(f)           methyl bromide at an inhaled concentration of >0.02 ppm;
(g)          methyl n-butyl ketone (MNBK) at an inhaled concentration of >0.6 ppm;
(h)          n-hexane at an inhaled concentration of >0.6 ppm; or
(i)            styrene at an inhaled concentration >5 ppm or at an oral dose rate of >0.1 mg/kg/day.
                               specified list of drugs means
(a)          almitrine bismesylate;
(b)          amiodarone;
(c)          arsenic trioxide;
(d)          atezolizumab;
(e)          bortezomib;
(f)           brentuximab vedotin;
(g)          carfilzomib;
(h)          cycloserine;
(i)            dichloroacetate;
(j)            disulfiram;
(k)          fludarabine;
(l)            fluoroquinolone antibiotics, excluding topical formulations;
(m)        ifosfamide;
(n)          ipilimumab;
(o)          isoniazid;
(p)          itraconazole;
(q)          linezolid;
(r)           methotrexate;
(s)           metronidazole;
(t)            misonidazole;
(u)          nitrofurantoin;
(v)          pemetrexed;
(w)        platinum compounds;
(x)          pomalidomide;
(y)          statins;
(z)          tacrolimus;
(aa)       taxanes;
(bb)      thalidomide;
(cc)       trastuzumab;
(dd)      trastuzumab emtansine;
(ee)       vigabatrin;
(ff)        vinca alkaloids; or
(gg)      zalcitabine (ddC).
                               specified list of drugs that cannot be ceased or substituted means:
(a)          5-fluorouracil;
(b)          acitretin;
(c)          adalimumab;
(d)          allopurinol;
(e)          altretamine;
(f)           amphotericin B;
(g)          auranofin;
(h)          aurothioglucose;
(i)            benznidazole;
(j)            brigatinib;
(k)          chloramphenicol;
(l)            chloroquine;
(m)        chlorprothixene;
(n)          colchicine;
(o)          crizotinib;
(p)          cytosine arabinoside;
(q)          dapsone;
(r)           daptomycin;
(s)           didanosine (ddI);
(t)            disopyramide;
(u)          encorafenib;
(v)          entrectinib;
(w)        eribulin mesylate;
(x)          etanercept;
(y)          ethambutol;
(z)          ethionamide;
(aa)       etoposide;
(bb)      etravirine;
(cc)       gemcitabine;
(dd)      glutethimide;
(ee)       griseofulvin;
(ff)        hexamethylmelamine;
(gg)      hydralazine;
(hh)      hydroxychloroquine;
(ii)         infliximab;
(jj)         interferon alpha;
(kk)      ixabepilone;
(ll)         lamivudine (3TC);
(mm) leflunomide;
(nn)      lenolidamide;
(oo)      levodopa;
(pp)      lithium;
(qq)      lorlatinib;
(rr)        mefloquine;
(ss)        nitrous oxide with prolonged use over 24 hours;
(tt)         nifurtimox;
(uu)      peginterferon alpha-2a;
(vv)      penicillamine;
(ww)  perhexiline maleate;
(xx)      phenelzine;
(yy)      phenytoin;
(zz)       podophyllin;
(aaa)   ponatinib;
(bbb)  procarbazine;
(ccc)   propafenone;
(ddd)  sorafenib;
(eee)   stavudine (d4T);
(fff)      sulphasalazine;
(ggg)  suramin;
(hhh)  telbivudine;
(iii)       teniposide;
(jjj)       teriflunomide;
(kkk)  tioguanine; or
(lll)       voriconazole.
                               specified list of endocrine diseases means:
(a)          acromegaly;
(b)          diabetes mellitus;
(c)          hyperthyroidism, including goitre and Graves disease that has resulted in hyperthyroidism;
(d)          hypothyroidism, including Hashimoto thyroiditis that has resulted in hypothyroidism; or
(e)          thyrotoxicosis.
Note: acromegaly is also